Skip to content
Home/Companies/Biotech/Alphalyse

Alphalyse

Biotech·Denmark·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Alphalyse?

Alphalyse is a Danish Biotech company, currently owned by Fidelio Capital since 2025.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Fidelio Capital
Investor
Fidelio Capital
Fidelio Capital · 2010 · Buyout

Key facts

HQDenmark
SectorBiotech
StatusActive

More from Fidelio Capital

Other portfolio companies in the same fund.

Audria
Active
PropTechSweden· 2025
Greenfood
Active
ConsumerSweden· 2025
Keyto
Active
ConsumerSweden· 2021
Lyko
Active
E-commerceSweden· 2021
iBinder
Active
SaaSSweden· 2019
Odevo
Active
Real EstateSweden· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Alphalyse?

Alphalyse is currently owned by Fidelio Capital, through Fidelio Capital, since 2025.

When did Fidelio Capital acquire Alphalyse?

Fidelio Capital acquired Alphalyse in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue